Overview

A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction

Status:
Unknown status

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

Sixty subjects will take part in this study. The subjects will be randomly assigned in a 1:1 ratio between the two arms of study. (Group A: Solution of Luffa Nasal Operculate 5mg/mL, Group B: saline). The subjects will use the study medication or comparative, according to their randomization, for a treatment period of 3 to 7 days. A follow-up visit will be made 15 days after initiation of treatment.

Phase:

Phase 3

Details

Lead Sponsor:

Zurita Laboratorio Farmaceutico Ltda.

Treatments:

Pharmaceutical Solutions